Binding/NN
characteristics/NNS
of/IN
the/DT
glucocorticoid/NN
receptor/NN
in/IN
peripheral/JJ
blood/NN
lymphocytes/NNS
in/IN
multiple/JJ
sclerosis/NN
./.

Although/IN
the/DT
exact/JJ
etiology/NN
of/IN
multiple/JJ
sclerosis/NN
(/(
MS/NN
)/)
remains/VBZ
unresolved/JJ
,/,
immune/JJ
reactions/NNS
are/VBP
believed/VBN
to/TO
be/VB
the/DT
central/JJ
pathogenic/JJ
mechanisms/NNS
./.
=====
Endogenous/JJ
and/CC
therapeutic/JJ
steroid/NN
hormones/NNS
affect/VBP
the/DT
immune/JJ
system/NN
,/,
and/CC
inflammatory/JJ
diseases/NNS
are/VBP
associated/VBN
with/IN
activation/NN
of/IN
the/DT
hypothalamic-pituitary-adrenal/JJ
axis/NN
,/,
providing/VBG
evidence/NN
of/IN
an/DT
immune-endocrine/JJ
interplay/NN
./.
=====
Function/NN
tests/NNS
in/IN
MS/NN
have/VBP
revealed/VBN
dysregulation/NN
of/IN
the/DT
hypothalamic-pituitary-adrenal/JJ
system/NN
in/IN
a/DT
substantial/JJ
proportion/NN
of/IN
patients/NNS
./.
=====
We/PRP
characterized/VBD
glucocorticoid/NN
receptor/NN
(/(
GR/NN
)/)
binding/NN
in/IN
peripheral/JJ
blood/NN
lymphocytes/NNS
from/IN
39/CD
MS/NN
patients/NNS
and/CC
14/CD
age-/NN
and/CC
sex-matched/JJ
controls/NNS
with/IN
respect/NN
to/TO
dissociation/NN
constant/NN
and/CC
binding/NN
capacity/NN
,/,
using/VBG
a/DT
whole-cell/JJ
binding/NN
assay/NN
with/IN
[3H]dexamethasone/NN
as/IN
the/DT
ligand/NN
./.
=====
GR/NN
binding/NN
parameters/NNS
did/VBD
not/RB
differ/VB
significantly/RB
between/IN
patients/NNS
(/(
Kd/NN
8.98/CD
+/-/CC
1.07/CD
nM/NN
,/,
Bmax/NN
183/CD
+/-/CC
29.8/CD
fmol/mg/NN
)/)
and/CC
controls/NNS
(/(
Kd/NN
9.36/CD
+/-/CC
1.17/CD
nM/NN
,/,
Bmax/NN
158/CD
+/-/CC
16/CD
fmol/mg/NN
)/)
./.
=====
No/DT
effect/NN
of/IN
age/NN
,/,
sex/NN
,/,
course/NN
,/,
duration/NN
or/CC
severity/NN
of/IN
disease/NN
,/,
or/CC
prior/JJ
steroid/NN
treatments/NNS
was/VBD
detected/VBN
./.
=====
GR/NN
binding/NN
parameters/NNS
were/VBD
analyzed/VBN
in/IN
relation/NN
to/TO
the/DT
results/NNS
of/IN
the/DT
combined/JJ
dexamethasone-CRH/JJ
test/NN
,/,
which/WDT
reflects/VBZ
corticosteroid/NN
receptor/NN
function/NN
at/IN
the/DT
hypothalamus/NN
,/,
in/IN
30/CD
patients/NNS
and/CC
9/CD
controls/NNS
./.
=====
While/IN
controls/NNS
showed/VBD
a/DT
moderate/JJ
correlation/NN
between/IN
binding/NN
affinity/NN
of/IN
the/DT
GR/NN
in/IN
lymphocytes/NNS
and/CC
regulatory/JJ
function/NN
at/IN
the/DT
hypothalamic/JJ
level/NN
,/,
the/DT
patients/NNS
did/VBD
not/RB
./.
=====
These/DT
data/NNS
suggest/VBP
that/IN
the/DT
physiological/JJ
relationship/NN
between/IN
binding/NN
and/CC
function/NN
of/IN
the/DT
glucocorticoid/NN
receptor/NN
is/VBZ
disturbed/VBN
in/IN
MS/NN
./.